First Time Loading...

Tango Therapeutics Inc
NASDAQ:TNGX

Watchlist Manager
Tango Therapeutics Inc Logo
Tango Therapeutics Inc
NASDAQ:TNGX
Watchlist
Price: 7.6 USD 3.97% Market Closed
Updated: May 15, 2024

Income Statement

Earnings Waterfall
Tango Therapeutics Inc

Revenue
37.2m USD
Operating Expenses
-163.4m USD
Operating Income
-126.1m USD
Other Expenses
14.5m USD
Net Income
-111.6m USD

Income Statement
Tango Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Revenue
Revenue
25
N/A
31
+28%
37
+18%
43
+16%
24
-44%
24
+1%
25
+3%
25
+0%
34
+36%
38
+11%
37
-3%
37
+2%
Operating Income
Operating Expenses
(41)
(68)
(95)
(126)
(116)
(127)
(136)
(141)
(148)
(147)
(151)
(163)
Selling, General & Administrative
(7)
(12)
(18)
(24)
(25)
(28)
(30)
(31)
(33)
(34)
(36)
(38)
Research & Development
0
(22)
(78)
(68)
(92)
(98)
(106)
(110)
(115)
(113)
(115)
(125)
Other Operating Expenses
(34)
(34)
0
(34)
0
0
0
0
0
0
0
0
Operating Income
(17)
N/A
(36)
-116%
(58)
-60%
(83)
-43%
(92)
-11%
(102)
-11%
(111)
-8%
(116)
-4%
(114)
+2%
(110)
+4%
(114)
-4%
(126)
-10%
Pre-Tax Income
Interest Income Expense
0
0
1
1
1
1
1
2
3
5
7
8
Total Other Income
0
(0)
(0)
(0)
(0)
0
1
3
4
5
6
7
Pre-Tax Income
(17)
N/A
(36)
-117%
(58)
-60%
(83)
-43%
(91)
-10%
(101)
-10%
(108)
-7%
(111)
-3%
(107)
+4%
(100)
+6%
(102)
-2%
(111)
-10%
Net Income
Tax Provision
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
Income from Continuing Operations
(17)
(36)
(58)
(83)
(92)
(101)
(108)
(111)
(107)
(100)
(102)
(112)
Net Income (Common)
(17)
N/A
(36)
-117%
(58)
-61%
(83)
-43%
(92)
-10%
(101)
-10%
(108)
-7%
(111)
-3%
(107)
+4%
(100)
+6%
(102)
-2%
(112)
-10%
EPS (Diluted)
-0.16
N/A
-0.51
-219%
-0.94
-84%
-0.94
N/A
-1.04
-11%
-1.15
-11%
-1.23
-7%
-1.26
-2%
-1.21
+4%
-1.03
+15%
-1.08
-5%
-1.03
+5%

See Also

Discover More